Inventor · disambiguated record
Twinkle R. Christian
Also filed as: CHRISTIAN TWINKLE R
7 granted patents·7 pending applications·7 citations·filing 2012–2025
75Inventor score
Top patents by PatentIndex Score
14 records- 0183US10611850B2Crystalline antibody formulationsAMGEN INC·Filed 2015·Granted Apr 7, 2020·5 cites·33 claims
- 0282US12473329B2Methods directed to crystalline biomoleculesAMGEN INC·Filed 2024·Granted Nov 18, 2025·0 cites·19 claims
- 0369US9145457B2Sclerostin antibody crystals and formulations thereofCLOGSTON CHRISTI L·Filed 2012·Granted Sep 29, 2015·2 cites·20 claims
- 0458US11773184B2Crystalline antibody formulationsAMGEN INC·Filed 2020·Granted Oct 3, 2023·0 cites·18 claims
- 0555US2025230241A1Low ph pharmaceutical antibody formulationAMGEN INC·Filed 2025·Application pending·0 cites
- 0652US9617333B2Sclerostin antibody crystals and formulations thereofAMGEN INC·Filed 2015·Granted Apr 11, 2017·0 cites·13 claims
- 0752US2021047407A1Low ph pharmaceutical antibody formulationAMGEN INC·Filed 2019·Application pending·0 cites
- 0851US11958882B2Methods directed to crystalline biomoleculesAMGEN INC·Filed 2018·Granted Apr 16, 2024·0 cites·10 claims
- 0950US11459401B2Reduced viscosity protein pharmaceutical formulationsAMGEN INC·Filed 2017·Granted Oct 4, 2022·0 cites·16 claims
- 1050US2023310324A1Method of making lyophilized protein formulationsAMGEN INC·Filed 2021·Application pending·0 cites
- 1149US2022275073A1Anti-Sclerostin Antibody FormulationsAMGEN INC·Filed 2020·Application pending·0 cites
- 1247US2022362104A1Systems and approaches for drug deliveryAMGEN INC·Filed 2020·Application pending·0 cites
- 1346US2023167175A1Pharmaceutical formulationAMGEN INC·Filed 2021·Application pending·0 cites
- 1445US2023167176A1Pharmaceutical formulationAMGEN INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →